ShunCong Zhang

ShunCong Zhang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2018 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
YLYong-Xian Li
Yong-Xian Li
DGDan-Qing Guo
Dan-Qing Guo
SZShunCong Zhang
ShunCong Zhang
DLDe Liang
De Liang
KYKai Yuan
Kai Yuan
PLPei-Jie Luo
Pei-Jie Luo

19 January 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
HLHaiShan Li
HaiShan Li
WDWei Deng
Wei Deng
JYJiaMin Yang
JiaMin Yang
YLYueWei Lin
YueWei Lin
SZShiYin Zhang
ShiYin Zhang
YLYongXian Li
YongXian Li
Osteoporosis is a systemic disease characterized by an imbalance in bone homeostasis, where osteoblasts fail to fully compensate for the bone resorption induced by osteoclasts. Corylifol A, a flavonoid extracted from Fructus psoraleae, has been identified as a potential treatment for this condition. Predictions from network pharmacology and molecular docking studies suggest that Corylifol A exhibits strong binding affinity with NFATc1, Nrf2, PI3K, and AKT1. Empirical evidence from in vivo experiments indicates that Corylifol A significantly mitigates systemic bone loss induced by ovariectomy by suppressing both the generation and activation of osteoclasts. In vitro studies further showed that Corylifol A inhibited the activation of PI3K-AKT and MAPK pathways and calcium channels induced by RANKL in a time gradient manner, and specifically inhibited the phosphorylation of PI3K, AKT, GSK3 β, ERK, CaMKII, CaMKIV, and Calmodulin. It also diminishes ROS production through Nrf2 activation, leading to a decrease in the expression of key regulators such as NFATcl, C-Fos, Acp5, Mmp9, and CTSK that are involved in osteoclastogenesis. Notably, our RNA-seq analysis suggests that Corylifol A primarily impacts mitochondrial energy metabolism by suppressing oxidative phosphorylation. Collectively, these findings demonstrate that Corylifol A is a novel inhibitor of osteoclastogenesis, offering potential therapeutic applications for diseases associated with excessive bone resorption.

15 September 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
DGDanqing Guo
Danqing Guo
MYMiao Yu
Miao Yu
HGHuizhi Guo
Huizhi Guo
MZMin Zeng
Min Zeng
YSYang Shao
Yang Shao
SZShunCong Zhang
ShunCong Zhang
Panax notoginseng (Burk) F. H. Chen has been a popular traditional Chinese medicine with long history for treating low back pain. Its main active ingredient, Panax notoginseng saponins (PNS), can be found in several Chinese patent medicines that are frequently used to treat blood stasis type low back pain. Intervertebral disc degeneration (IDD) is the most common cause of back pain, and the injection of PNS has been used to relieve IDD-induced back pain in clinical practice. Despite its effectiveness, the exact mechanisms of action for PNS injections remain unclear. IDD as a consequence of aging involves apoptosis of nucleus pulposus (NP) cells and imbalanced degradation of extracellular matrix (ECM) induced by several factors including oxidative stress. We hypothesized that PNS may have therapeutic effect on IDD via inhibiting apoptosis of NP cells and degradation of ECM under oxidative stress. In this study, network pharmacology was initially employed to predict the target of PNS against IDD. Subsequently, commercial PNS was analyzed by high-performance liquid chromatography to comfirm the ingrediants for in vitro and in vivo experiments. In vitro experiments were conducted on human nucleus pulposus cells, including CCK-8, RT-PCR, Western blot, immunofluorescence staining, autophagic flux detection and TUNEL assay. In vivo experiments were also performed on rats with IDD of tail discs induced by annular fibrosus needle puncture, which involved MRI, HE staining, and immunohistochemistry. Our study demonstrated the theoretical targets of PNS against IDD, including Caspase 3, MMP13, Akt, and autophagy, based on network pharmacology. Subsequently, in vitro experiments revealed that PNS attenuated cellular apoptosis of NP by suppressing the expression of cleaved-caspase 3 and the ratio of Bax/Bcl-2 under H2O2 stimulation. Autophagy was also inhibited by PNS treatment, and the protective effect was abolished with rapamycin, an autophagy inducer, indicating that autophagy inhibition was involved in the protective effect of PNS on IDD. Furthermore, Akt/mTOR pathway activation was observed in HNP cells responding to H2O2 with PNS treatment, which played a role in autophagy downregulation. PNS was also shown to promote the expression of anabolic genes such as Col2a1 and ACAN while inhibiting the expression of catabolic gene MMP13 in HNP cells. In addition, the in vivo study revealed that PNS treatment could ameliorate IDD in a puncture-induced rat tail model. The development of IDD was significantly reduced, and there was decreased MMP13 expression, as well as increased Col2a1 protein expression in NP tissues. Our study showed that PNS could protect HNP cells against apoptosis via autophagy inhibition and ameliorate disc degeneration in vivo, indicating its potential to be a therapeutic agent for IDD.

28 July 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
YLYongxian Li
Yongxian Li
SLSipeng Lin
Sipeng Lin
PLPanjie Liu
Panjie Liu
JHJianbin Huang
Jianbin Huang
JQJunxiong Qiu
Junxiong Qiu
SZShunCong Zhang
ShunCong Zhang

13 March 2023 in Biochemical Pharmacology
Verified
Journal Article
Open access
HLHaiShan Li
HaiShan Li
WDWei Deng
Wei Deng
QQQiuLi Qin
QiuLi Qin
YLYueWei Lin
YueWei Lin
TLTeng Liu
Teng Liu
SZShunCong Zhang
ShunCong Zhang
Osteoporosis, an immune disease characterized by bone mass loss and microstructure destruction, is often seen in postmenopausal women. Isoimperatorin (ISO), a bioactive, natural furanocoumarin isolated from many traditional Chinese herbal medicines, has therapeutic effects against various diseases; however, its effect on bone homeostasis remains unclear. In this study, we investigated the effect of ISO on the differentiation and activation of osteoclast and its molecular mechanism in vitro, and evaluated the effect of ISO on bone metabolism by ovariectomized (OVX) rat model. In vitro experiments showed that ISO affected RANKL-induced MAPK, NFAT, NFATc1 trafficking and expression, osteoclast F-actin banding, osteoclast-characteristic gene expression, ROS inhibitory activity, and calcium oscillations, NF-κB signaling pathway. In vivo experiments showed that oral administration of ISO effectively reduced bone loss caused by ovariectomy and retained bone mass.Collectively, ISO inhibits RANK/RANKL binding, thereby reducing the activity of NFATc1, calcium, and ROS and inhibiting osteoclast generation. In addition, ISO protects bone mass by slowing osteoclast production and downregulating NFATc1 gene and protein expression in the bone tissue microenvironment and inhibits OVX-induced bone loss in vivo.

26 February 2023 in Biochemical Pharmacology
Verified
Journal Article
Closed access
WDWei Deng
Wei Deng
HLHaiShan Li
HaiShan Li
YZYaYa Zhang
YaYa Zhang
YLYueWei Lin
YueWei Lin
CCChiWei Chen
ChiWei Chen
SZShunCong Zhang
ShunCong Zhang